Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
Joint Authors
Egbert, Ryan Carlisle
Folsom, Ryan
Bell, Jeff
Rajani, Rajiv
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-05-10
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Case.
A 68-year-old female was diagnosed with giant cell tumor of bone (GCTB) metastatic to her lungs.
The patient was treated with IV denosumab for the course of 4.5 years for these metastases.
The metastatic tumor burden decreased significantly after only 3 months of therapy.
The size of the metastases has been stable for over 4 years.
Conclusion.
Denosumab therapy has promise in the treatment of GCTB, including pulmonary metastasis.
However, the long-term role of denosumab for pulmonary metastases is yet to be determined.
American Psychological Association (APA)
Egbert, Ryan Carlisle& Folsom, Ryan& Bell, Jeff& Rajani, Rajiv. 2017. Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis. Case Reports in Orthopedics،Vol. 2017, no. 2017, pp.1-4.
https://search.emarefa.net/detail/BIM-1148211
Modern Language Association (MLA)
Egbert, Ryan Carlisle…[et al.]. Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis. Case Reports in Orthopedics No. 2017 (2017), pp.1-4.
https://search.emarefa.net/detail/BIM-1148211
American Medical Association (AMA)
Egbert, Ryan Carlisle& Folsom, Ryan& Bell, Jeff& Rajani, Rajiv. Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis. Case Reports in Orthopedics. 2017. Vol. 2017, no. 2017, pp.1-4.
https://search.emarefa.net/detail/BIM-1148211
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1148211
